Clostridium perfringens is an important pathogen in veterinary and medical fields. Understanding epidemiology of C. perfringens diseases and evolution of virulence within C. perfringens necessitates an efficient, time and cost effective strain typing method. Multiple-locus variable-number tandem repeat analysis (MLVA) has been applied to typing of other pathogens and we describe here the development of a MLVA scheme for C. perfringens. We characterized five VNTR loci, and screened 112 C. perfringens isolates to evaluate typability, reproducibility, and discriminatory power of the scheme. All isolates were assigned a MLVA genotype and the technique has excellent reproducibility, with a numerical index of discrimination of 0.995. Thus, MLVA is an efficient tool for C. perfringens strain typing, and being PCR based makes it rapid, easy, and cost effective. In addition, it can be employed in epidemiological, ecological, and evolutionary investigations of the organism.Virulence of this species is not fully understood and it does seem that distribution of the toxin/enzyme genes is erratic within the population. We used the MLVA scheme to investigate evolution of virulence and population structure of this species. Analysis of the phylogenetic signal indicates that acquisition of the major toxin genes and other plasmid-borne toxin genes is a recent evolutionary event, and their maintenance is essentially a function of the selective advantage they confer to strains carrying them in certain micro-niches under different conditions. In addition, it indicates the ability of virulent strains to cause disease in different hosts. More interestingly, there is evidence that certain normal flora strains are virulent when they gain access to a different host species. Analysis of the population structure indicates that recombination events are the major tool that shapes the population and this panmixia is interrupted with frequent clonal expansion that mostly corresponds to disease processes. Signature of positive selection was detected in the alpha toxin gene, suggesting the possibility of adaptive alleles on the other chromosomally-encoded determinants. Finally, C. perfringens proved to have a dynamic population, and availability of more genome sequences, use of comparative proteomics and of animal models would provide more insight into the pathogenicity of this organism.

In the United States, symptoms caused by pathogenic strains of Escherichia coli are on the rise. A major source of these pathogenic strains is the E. coli in the digestive tract of cattle. The purpose of this project was to determine if E. coli are transferred between individuals of the same species and if interspecies transmission is possible. Proximity of cattle was also studied as a contributing factor to the transfer of E. coli. To accomplish this goal, E. coli isolates from cattle and cohabitating ground squirrels were compared through a new method of bacterial strain typing called pyroprinting. Bulls from the Cal Poly Bull Test were sampled every summer from May to September when around 200 bulls from ranches across California are housed together to be tested and eventually auctioned off. The impact of cattle origin (ranch, city) and habitation (pen) on E.coli isolate strain type were evaluated via pyroprinting . The cattle were studied to see if transfer was related to proximity of cohabitation. Since the complete population of intestinal E. coli could not be sampled, transfer could not be directly seen. The probability of sharing E. coli in each time point was used to infer transfer. There was an increase in the probability of sharing E. coli from the May sample date to the September date, indicating that some form of transfer was occurring. There was an even greater increase in the probability of sharing E. coli when the bulls were housed in close proximity. Lastly, ground squirrels cohabitating in the area were found to house some of the same strains as the cattle. This makes transfer between squirrels and cattle a possibility. Overall, this paper shows that the intestinal E. coli composition of bulls may be readily altered by the introduction of new bulls into a population.

The genus Mycobacterium contains many pathogenic bacteria that are known to cause serious diseases in humans. One of the most well-known of these bacteria is Mycobacterium tuberculosis, or Mtb, which is the causative agent of tuberculosis. It infects nearly one-third of the world’s population and kills 1.4 million people annually. Another important mycobacterial pathogen is Mycobacterium abscessus, or Mabs, which causes respiratory infections in cystic fibrosis patients. One of the biggest difficulties in combating these pathogens is the lack of effective diagnostics, as current strategies hold many pitfalls and can be unreliable. One common method used is sputum smear microscopy which involves acid fast staining of the bacteria present in a patient’s sputum. This method of detection fails to detect more than 50% of infections and is unable to differentiate between species of mycobacterium. This project introduces a novel method of mycobacterial diagnostics using binary deoxyribozymes (DNAzymes). Binary DNAzymes recognize bacteria-specific nucleic acid sequences and bind to them, forming a catalytic core which cleaves a substrate molecule. This cleavage separates a quencher molecule from a fluorophore, which results in a fluorescent output. This flexible assay platform has great potential for the detection of Mtb or Mabs. Our data shows the specificity of the DNAzymes allowing for a differential diagnosis of various species of Mycobacteria. It also shows the limit of detection of this technology and its additional utility in molecular typing of Mtb clinical isolates as well as drug resistance characterization. This multipurpose tool can contribute to disease management in multiple ways.

Descoberto e caracterizado em 1909 por Carlos Chagas, o Trypanosoma cruzi é o agente etiológico da Doença de Chagas. Durante a fase crônica da doença de Chagas, onde a parasitemia é baixa, o diagnóstico se baseia na busca de anticorpos contra os antígenos de T. cruzi no sangue. Para aumentar a certeza do resultado recomenda-se o uso de pelo menos dois métodos sorológicos (geralmente ensaio ELISA, Imunofluorescência Indireta ou Hemaglutinação Indireta) para a confirmação de diagnóstico. Embora os ensaios mencionados sejam de uso amplamente difundido, nenhum deles possui suficiente especificidade para definir o diagnóstico isoladamente, especialmente em pacientes provenientes de regiões onde há sobreposição geográfica com outros parasitos, especialmente do gênero Leishmania ou T. rangeli. Uma alternativa de interesse que foi levantada por alguns autores na década de oitenta é a busca de moléculas de interesse diagnóstico (anticorpos, antígenos ou imunocomplexos) na urina de pacientes. Durante os últimos anos técnicas de proteômica têm sido aplicadas a muitos campos da medicina. Uma das aplicações é na nefrologia para o melhor entendimento da fisiologia renal, explorar a complexidade de mecanismos de doenças e para identificar novos biomarcadores. Além do mais, a maioria das proteínas na urina são glicosiladas e suas propriedades são únicas fazendo delas uma importante fonte de biomarcadores. De maneira geral, percebe-se que apesar dos avanços significativos nos métodos de diagnósticos para a detecção da infecção por T. cruzi, há algumas lacunas que ainda precisam ser preenchidas. O fato de que a sorologia convencional para busca de anticorpos IgGs manter-se-á positiva ao longo da vida do paciente, mesmo após tratamento devido a persistência da resposta imune humoral, é uma limitação, já que não permite ter um critério confiável de cura. Por outro lado, a falta de um sistema rápido e confiável para acompanhar a evolução do tratamento, gera sérias limitações para avaliar o desempenho de novos protocolos de tratamento com fármacos já existentes ou de novos fármacos. Em função dessas limitações, propõe-se desenvolver e validar novos métodos de diagnóstico baseado em espectrometria de massas para a detecção da infecção pelo T. cruzi utilizando a urina como fonte de biomarcadores. / Discovered and characterized in 1909 by Carlos Chagas, Trypanosoma cruzi is the etiologic agent of Chagas\' disease. During the chronic phase of Chagas\' disease, where parasitemia is low, the diagnosis is based on the search for antibodies against T. cruzi antigens in the blood. To increase the certainty of the result, is recommended two serological methods (usually ELISA, Indirect Immunofluorescence or Indirect Hemagglutination) for diagnostic confirmation. Although the aforementioned assays are widely used, none of them has sufficient specificity to define the diagnosis alone, especially in patients from regions where there is geographical overlap with other parasites, especially of the genus Leishmania or T. rangeli. An interesting alternative that was raised by some authors in the 1980s is the use of molecules of diagnostic interest (antibodies, antigens or immunomplexes) in the patients\' urine. During the last years techniques of proteomics have been applied to many fields of medicine. One of the applications is nephrology for the better understanding of renal physiology, to explore the completeness of disease mechanisms and identify new biomarkers. Moreover, most of the proteins in the urine are glycosylated. Their properties are unique, making them an important source of biomarkers. In general, perceived that despite significant advances in diagnostic methods for the detection of T. cruzi infection, there are some gaps that need to be filled. The fact that conventional IgG antibody serology will remain positive over the life of the patient, despite the persistence of the humoral immune response, is a limitation, since it does not allow a reliable criterion of cure. On the other hand, the lack of a reliable system to follow the evolution of the treatment generates serious limitations to evaluate the performance of new treatment protocols with existing drugs or new drugs. Due to these limitations, we propose to develop new methods of diagnosis based on mass spectrometry for the detection of T. cruzi infection using urine as a source of biomarkers.

The epidemiology of blastomycosis remains poorly understood in part due to the lack of a robust and discriminatory strain typing method for Blastomyces dermatitidis. Here we describe the development of a multilocus sequence (MLST) method to study the genetic variation and population structure of B. dermatitidis. Eighty geographically diverse clinical and environmental isolates were examined. Thirty-six unique sequence types were identified. With a discriminatory index of 91.4%, MLST identifies significant genetic diversity for the characterization of local and global B. dermatitidis isolates. To test whether this fungus represented a single species throughout its geographic range we performed phylogenetic analyses, applying Genealogical Concordance Phylogenetic Species Recognition (GCPSR). Phylogenetic analysis revealed two distinct clades, with five of the eight gene phylogenies studied supporting the separation of these lineages, which were also geographically partitioned. Based on fulfillment of GCPSR, we propose the current species B. dermatitidis harbors two genetically distinct non-interbreeding phylogenetic species.

The epidemiology of blastomycosis remains poorly understood in part due to the lack of a robust and discriminatory strain typing method for Blastomyces dermatitidis. Here we describe the development of a multilocus sequence (MLST) method to study the genetic variation and population structure of B. dermatitidis. Eighty geographically diverse clinical and environmental isolates were examined. Thirty-six unique sequence types were identified. With a discriminatory index of 91.4%, MLST identifies significant genetic diversity for the characterization of local and global B. dermatitidis isolates. To test whether this fungus represented a single species throughout its geographic range we performed phylogenetic analyses, applying Genealogical Concordance Phylogenetic Species Recognition (GCPSR). Phylogenetic analysis revealed two distinct clades, with five of the eight gene phylogenies studied supporting the separation of these lineages, which were also geographically partitioned. Based on fulfillment of GCPSR, we propose the current species B. dermatitidis harbors two genetically distinct non-interbreeding phylogenetic species.